NEW

Stock Screener with Intrinsic Value

TRY FOR FREE

Alnylam Pharmaceuticals, Inc. (ALNY)

Last Price$246.3(1.2%)

Market Cap$31.7B

Shareholder Yield LTM

0.0%

5Y avg

0.0%

Biotechnology industry median

0.0%

Stock quality & Intrinsic value

Start beating the S&P 500

Alnylam Pharmaceuticals, Inc. Shareholder Yield LTM

Annual

Quarterly

Daily

Crunching data... Almost there!

	Dec'04	Dec'05	Dec'06	Dec'07	Dec'08	Dec'09	Dec'10	Dec'11	Dec'12	Dec'13	Dec'14	Dec'15	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23
Shareholder Yield LTM	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

ALNY

Key metrics and insights to make informed decisions.

View full analysis

Overvalued or undervalued?

Check the intrinsic value for ALNY and see if it's the right time to invest.

Dive in

Alnylam Pharmaceuticals, Inc. (ALNY) Shareholder Yield LTM comparison analysis

Crunching data... Almost there!

ALNY key stats

USD

Millions

Billions

Annual

Quarterly

Trailing

Key stats

Income statement

Balance sheet

Cash Flow Statement

Valuation

Ratios

Per share

Per employee

Dividends & Yields

Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

More ideas -->

Loved by
investors
worldwide

10K+

Investors use our platform

Top value investing hub with all necessary tools

1K+

Experienced investors in our community

4.9

Average rating across all rating platforms

Start for free ->

FAQ

1) What is Alnylam Pharmaceuticals, Inc.'s Shareholder Yield LTM?

As of today, Microsoft Corp's last 12-month Shareholder Yield LTM is 0.0%, based on the financial report for Sep 27, 2024 (Q3 2024). The average annual Shareholder Yield LTM for Alnylam Pharmaceuticals, Inc. have been 0.0% over the past three years, and 0.0% over the past five years.

2) Is Alnylam Pharmaceuticals, Inc.'s Shareholder Yield LTM Good?

As of today, Alnylam Pharmaceuticals, Inc.'s Shareholder Yield LTM is 0.0%, which is lower than industry median of N/A. It indicates that Alnylam Pharmaceuticals, Inc.'s Shareholder Yield LTM is Bad.

3) How does Alnylam Pharmaceuticals, Inc.'s Shareholder Yield LTM compare to its peers?

As of today, Alnylam Pharmaceuticals, Inc.'s Shareholder Yield LTM is 0.0%, which is lower than peer median of 1.9%. The list of peers includes INCY, UTHR, RPRX, REGN, NVO, VRTX, BNTX, BGNE, SMMT, ARGX.